参考文献/References:
［1］HENDRIX S L, CLARK A, NYGAARD I, et al Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity ［J］. American Journal of Obstetrics and Gynecology, 2002, 186 (6): 1160-1166.
［2］Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA) / International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP)［J］. International Urogynecology Journal，2016， 27（2）: 165-194.
［3］Food, Drug Administration. FDA safety communication:update on serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse ［Z］, 2011.
［4］WITHAGEN M I, MILANI A L, DEN BOON J A, et al. Trocar-Guided mesh compared with conventional vaginal repair in recurrent prolapse a randomized controlled trial［J］. Obstetrics and Gynecology, 2011, 117 (2, 1): 242-250.
［5］ALTMAN D,VAYRYNEN T,ENGH M E,et al.Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse［J］. New England Journal of Medicine, 2011, 364 (19): 1826-1836.
［6］MARGULIES R U, LEWICKY-GAUPP C, FENNER D E, et al. Complications requiring reoperation following vaginal mesh kit procedures for prolapse［J］. American Journal of Obstetrics and Gynecology, 2008, 199 (6): 678.e1-678.e4.
［7］MAHER C F, FEINER B, DECUYPER E M, et al. Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: a randomized trial［J］. American Journal of Obstetrics and Gynecology, 2011, 204 (4): 360.e1-360.e7.
［8］Committee on Gynecologic Practice，Vaginal placement of synthetic mesh for pelvic organ prolapse［J］. Female pelvic medicine & reconstructive surgery，2012, 18 (1):5-9.
［9］朱兰，陈娟．关于美国FDA对经阴道网片安全警示的中国专家共识建议稿.In:第八届北京大学女性盆底重建与微创手术研讨会论文集［C］//北京，2012：10-14．
［10］CUNDIFF G W. Mesh in POP surgery should be based on the risk of the procedure, not the risk of recurrence［J］. International Urogynecology Journal, 2017, 28 (8): 1115-1118.